Chugai Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	434,012	387,317	325,472	374,429	302,995
Depreciation & Amortization	32,535	31,665	31,740	31,434	30,868
Loss (Gain) From Sale of Assets	-8,027	4,377	-21,881	641	6,342
Asset Writedown & Restructuring Costs	12,554	-	-	-	-
Stock-Based Compensation	483	-	-	-	-
Other Operating Activities	-5,626	-101,510	-180,718	-152,074	-104,102
Change in Other Net Operating Assets	-79,651	125,751	255,312	-10,318	43,523
Operating Cash Flow	386,280	447,600	409,925	244,112	279,626
Operating Cash Flow Growth	-13.70%	9.19%	67.92%	-12.70%	36.38%
Capital Expenditures	-76,273	-50,415	-71,948	-62,625	-65,969
Sale of Property, Plant & Equipment	7,509	-510	19,346	1,048	1,042
Sale (Purchase) of Intangibles	-35,306	-1,685	12,850	-8,614	-6,897
Investment in Securities	-100,804	-177,539	979	-76,083	-47,236
Other Investing Activities	3,601	2,784	1,483	280	133
Investing Cash Flow	-201,273	-227,365	-37,290	-145,994	-118,927
Long-Term Debt Repaid	-8,176	-	-	-	-
Net Debt Issued (Repaid)	-8,176	-	-	-	-
Issuance of Common Stock	142	168	217	241	322
Repurchase of Common Stock	-6	-10	-5	-5	-8
Common Dividends Paid	-299,419	-133,249	-131,594	-138,220	-98,644
Other Financing Activities	-427	-7,915	-7,949	-7,657	-9,078
Financing Cash Flow	-307,886	-141,006	-139,331	-145,641	-107,408
Foreign Exchange Rate Adjustments	9,279	2,299	3,202	1,939	2,128
Miscellaneous Cash Flow Adjustments	-	-	-1	-	-
Net Cash Flow	-113,600	81,528	236,505	-45,584	55,419
Free Cash Flow	310,007	397,185	337,977	181,487	213,657
Free Cash Flow Growth	-21.95%	17.52%	86.23%	-15.06%	44.37%
Free Cash Flow Margin	24.64%	33.93%	30.41%	14.40%	21.37%
Free Cash Flow Per Share	188.37	241.36	205.40	110.30	129.87
Cash Interest Paid	429	94	81	58	48
Cash Income Tax Paid	191,104	100,477	176,074	152,082	104,074
Levered Free Cash Flow	259,493	338,816	317,041	148,160	177,704
Unlevered Free Cash Flow	259,622	338,813	317,058	148,198	177,734
Change in Working Capital	-79,651	125,751	255,312	-10,318	43,523

Source: S&P Global Market Intelligence. Standard template. Financial Sources.